Ketamine Nasal Spray is approved as a standalone treatment for difficult cases of depression.

Emerging treatments for clinical depression have reached a milestone: This week, the Food and Drug Administration approved Johnson & Johnson's ketamine-containing nasal spray, named Spravato for use as a standalone treatment for cases of depression that have not responded to…